Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia
Clinical trial NCT01662648 · COMPLETED
Trial details
- NCT number
- NCT01662648
- Sponsor
- Janssen Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2008-04-01
- Enrollment
- 1117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.